title: Successful sequential treatment with itraconazole and ALA-PDT for chromoblastomycosis because of Alternaria alternata.
abstract: Alternaria alternata is a rare etiology of phaeohyphomycosis in immunocompromised patients, which has never been reported to cause chromoblastomycosis. As far as we know, this is the first chromoblastomycosis case successfully treated with a short course of systemic antifungals and subsequent 5-aminolevulinic acid-photodynamic therapy.
authors.affiliation: Department of Dermatology, Affiliated Third Hospital of Hangzhou, Anhui Medical University, Hangzhou, China.
authors.forename: Ze-Hu
authors.initials: ZH
authors.lastname: Liu
authors.forename: Xiu-Jiao
authors.initials: XJ
authors.lastname: Xia
mesh_terms: D000528:Alternaria / Q000302:isolation & purification*; D060487:Alternariosis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D000622:Aminolevulinic Acid / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002862:Chromoblastomycosis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D003131:Combined Modality Therapy; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D011838:Radiation-Sensitizing Agents; D017964:Itraconazole; D000622:Aminolevulinic Acid
keywords: chromoblastomycosis; itraconazole; photodynamic therapy